The Aminoglycoside Antibiotics Market is expected to see robust growth in the Asia-Pacific region, driven by increasing healthcare infrastructure investments and rising incidence of infectious diseases.

Countries like China and India are expanding hospital capacities and improving antibiotic access, contributing to higher aminoglycoside consumption.

Affordable generic options and government initiatives to combat antimicrobial resistance further support market expansion in this region.